TATA Health International Holdings Limited announces that Prof. Yan Haifeng (Prof. Yan) had tendered his resignation as an independent non-executive Director with effect from 12 May 2022, as he desires to devote more time to his other business commitments. The Board also announces that Mr. Wang Jian ("Mr. Wang'') has been appointed as an independent non-executive Director with effect from 12 May 2022. He is qualified as a certified public accountant under the Association of Chartered Certified Accountants and a licensed certified public accountant in various countries/regions such as Cambodia and the Association of Southeast Asian Nations. The Board further announces that, with effect from 12 May 2022: Prof. Yan ceased to be the chairman of the Remuneration Committee and a member of each of the Audit Committee and the Nomination Committee, due to his
resignation as an independent non-executive Director; Mr. Xie Rongxing, an independent non-executive Director, ceased to be the chairman of the Audit Committee but remained as a member of the Audit Committee, and has been appointed as the chairman of the Remuneration
Committee; and Mr. Wang has been appointed as the chairman of the Audit Committee and a member of each of the Remuneration Committee and the Nomination Committee.